<i>Listeria monocytogenes</i> bacteremia developed during treatment of COVID-19.

Yamamoto, Jin; Nakamoto, Keitaro; Shimasaki, Teppei; Kurai, Daisuke; Saraya, Takeshi; Ishii, Haruyuki

Listeria monocytogenes bacteremia developed during treatment of COVID-19.

Yamamoto, Jin; Nakamoto, Keitaro; Shimasaki, Teppei; Kurai, Daisuke; Saraya, Takeshi; Ishii, Haruyuki.

Afiliación

Yamamoto J; Department of Nephrology and Rheumatology Kyorin University School of Medicine Mitaka Tokyo Japan.
Nakamoto K; Department of Respiratory Medicine Kyorin University School of Medicine Mitaka Tokyo Japan.
Shimasaki T; Department of General Medicine Kyorin University School of Medicine Mitaka Tokyo Japan.
Kurai D; Department of General Medicine Kyorin University School of Medicine Mitaka Tokyo Japan.
Saraya T; Department of Respiratory Medicine Kyorin University School of Medicine Mitaka Tokyo Japan.
Ishii H; Department of Respiratory Medicine Kyorin University School of Medicine Mitaka Tokyo Japan.

Clin Case Rep ; 11(11): e8115, 2023 Nov.

Article en En | MEDLINE | ID: mdl-37908788

RESUMEN

Listeria monocytogenes is an important pathogen in older patients and immunosuppressed patients, often causing bacteremia. Complications resulting from infections other than COVID-19 must also be considered during COVID-19 treatment.

Palabras clave

COVID19; Listeria monocytogenes; bacteremia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Clin Case Rep Año: 2023 Tipo del documento: Article